5 Large-cap Stocks with Highest Dividends

In this article, we will take a lot at the 5 Large-cap Stocks with Highest Dividends. For a deeper analysis and discussion, please check out our list of the 15 Large-cap Stocks with Highest Dividends.

5. Verizon Communications Inc. (NYSE:VZ)

Dividend Yield as of March 28: 5.63%

Next on our list of the Stocks with the Highest Dividends is Verizon Communications Inc. (NYSE:VZ). The company engages in the provision of communications, technology, information, and streaming products and services to consumers, businesses, and governmental entities worldwide.

On March 20, Citi analyst Michael Rollins bumped the firm’s price target on Verizon Communications Inc. (NYSE:VZ) from $50 to $55, while maintaining a ‘Buy’ rating on the shares. The raised target indicates an upside of over 9% from the current share price.

The move comes after Citi sees ‘positive optionality’ from Verizon’s streamlined cost structure and expanded converged services. The analyst believes that the firm has the potential to return to annual service revenue growth next year and build on its EBITDA and free cash flow.

Verizon Communications Inc. (NYSE:VZ) is projecting its FY 2026 adjusted EBITDA to be in the range of $4.90 to $4.95, representing a YoY growth of 4% to 5%. The company expects its free cash flow to reach $21.5 billion or more during the year, up by about 7% or more compared to 2025. Meanwhile, the firm’s CapEx guidance for FY 2026 stands at $16 billion to $16.5 billion, down $4 billion from the combined 2025 expenditures of Verizon and Frontier.

4. Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR)

Dividend Yield as of March 28: 5.71%

Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR) is one of the largest oil and gas producers in the world. The Brazilian company is mainly dedicated to exploration and production, refining, energy generation, and marketing.

On March 23, Goldman Sachs analyst Bruno Amorim bumped the company’s price target on Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR) from $15 to $19.50, while maintaining a ‘Buy’ rating on the shares.

Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR) delivered record exports of 1.2 million barrels per day of oil and derivatives in Q4 2025, up by around 79% YoY. This is because the company’s oil production in Brazil surged by about 20% YoY during the quarter to 2.5 million bpd. A significant advantage for the energy giant stems from its predominantly dollar-linked revenues tied to international oil benchmarks, insulating it from the volatility linked to the Brazilian real and ensuring substantial hard currency exposure.

With a robust annual dividend yield of 5.98%, Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR) was recently included in our list of the 13 Oil Stocks with Highest Dividends.

3. ING Groep N.V. (NYSE:ING)

Dividend Yield as of March 28: 5.99%

ING Groep N.V. (NYSE:ING) is a global bank with a strong European base. Its more than 60,000 employees offer retail and wholesale banking services in over 100 countries around the world.

ING Groep N.V. (NYSE:ING) had a setback on March 23 when Morgan Stanley downgraded the stock from ‘Overweight’ to ‘Equal Weight’, while assigning it a price target of €28. The target still indicates an upside of over 25% from the current levels.

The move comes after Morgan Stanley recommended taking a more defensive stance on the European banks. The analyst firm sees multiple risk factors amid a lack of clarity for investors.

That said, ING Groep N.V. (NYSE:ING) is targeting its total income to grow by over 4% YoY to around €24 billion in 2026. The bank then intends to continue this momentum and deliver a total income exceeding €25 billion in 2027.

As of the writing of this piece, the share price of ING Groep N.V. (NYSE:ING) has fallen by over 10% since the beginning of 2026. However, the stock currently has a forward P/E ratio of 9.05 and was recently included in our list of the 11 Undervalued European Stocks to Buy Now.

2. Pfizer Inc. (NYSE:PFE

Dividend Yield as of March 28: 6.36%

Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company’s global portfolio includes medicines and vaccines, as well as many of the world’s best-known consumer health care products.

Pfizer Inc. (NYSE:PFE) and Valneva announced on March 23 that their Lyme disease vaccine showed more than 70% efficacy in a late-stage study, even as it missed its key statistical requirement meant to ensure reliability. According to the drugmaker, the key reason for missing the goal was that there were not enough people in the study who contracted Lyme disease to be confident in the results. However, the partners deem the overall results encouraging and now plan ​to move ahead with regulatory submissions.

There is currently no approved vaccine to prevent Lyme disease, which is spread by bites from infected blacklegged ticks. Pfizer’s vaccine ⁠demonstrated 73.2% efficacy starting 28 days after the fourth dose in reducing ​confirmed Lyme disease cases, compared to the placebo. Valneva is estimating the vaccine to achieve peak annual sales of $1 billion.

Annaliesa Anderson, Ph.D., Senior Vice President and Chief Vaccines Officer at Pfizer Inc. (NYSE:PFE), commented:

“Lyme disease can cause potentially serious consequences – where individuals and families face symptoms that can disrupt daily life, work, and long-term health – and there is currently no vaccine available. The efficacy shown in the VALOR study of more than 70% is highly encouraging and creates confidence in the vaccine’s potential to protect against this disease that can be debilitating.”

1. Altria Group, Inc. (NYSE:MO)

Dividend Yield as of March 28: 6.38%

Topping our list of the Large Cap Stocks with the Highest Dividends is Altria Group, Inc. (NYSE:MO). It is an American tobacco company that manufactures a wide range of related products, including cigarettes and other nicotine products.

Altria Group, Inc. (NYSE:MO) announced on March 23 that it is expanding the distribution of its on! PLUS nicotine pouches to retailers nationwide. The product had previously been launched online and at participating retailers in North Carolina, Florida, and Texas.

on! PLUS is a next-generation, sit-free oral nicotine pouch made by Helix, an Altria operating company. It is the first product authorized through the FDA’s pilot program designed to expedite the review of premarket tobacco product applications. It comes in three flavors and two nicotine strengths. on! PLUS is now expected to reach participating retailers across the country starting March 23.

Nick MacPhee, Managing Director at Helix, commented:

“The national expansion of on! PLUS is an exciting milestone for Helix and a meaningful step forward in Altria’s Vision of Moving Beyond Smoking ®. As adult consumers continue to seek smoke‑free alternatives, on! PLUS reflects our focus on quality, innovation, and responsibly meeting demand within science‑based regulatory frameworks.”

Known for its high shareholder distributions, Altria Group, Inc. (NYSE:MO) bumped its dividend by 3.9% in 2025, marking the 60th increase in the last 56 years. The company intends to build on this momentum and target a mid-single-digit dividend per share growth annually through 2028.

With an annual dividend yield of 6.65%, Altria Group, Inc. (NYSE:MO) is placed among the 14 Best American Dividend Stocks to Invest in.

While we acknowledge the potential of MO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MO and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 15 Dividend Stocks to Buy for Steady Income and Dividend Kings and Aristocrats List: 32 Biggest Stocks

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.